Judy Hejingdao Wu
Chief Operating Officer at ASCLETIS PHARMA INC.
Net worth: 15 M $ as of 2024-03-30
Profile
Judy Hejingdao Wu is currently working as a Director at Ascletis Biopharmaceutical (Hangzhou) Co. Ltd., as a Senior VP-Operations & Executive Director at Ascletis Pharma, Inc., as a Director & Vice President at Ascletis BioScience Co., Ltd., and as a Manager at Gannex LLC.
Previously, she worked as a Vice President at Ascletis Pharmaceuticals Co., Ltd.
Ms. Wu completed her undergraduate degree from Zhejiang University in 1996.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ASCLETIS PHARMA, INC.
8.18% | 2024-03-04 | 82,827,414 ( 8.18% ) | 15 M $ | 2024-03-30 |
Judy Hejingdao Wu active positions
| Companies | Position | Start |
|---|---|---|
| ASCLETIS PHARMA INC. | Chief Operating Officer | - |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Director/Board Member | - |
| Ascletis BioScience Co., Ltd. | Director/Board Member | 2013-12-31 |
| Gannex LLC | Corporate Officer/Principal | 2020-12-31 |
Former positions of Judy Hejingdao Wu
| Companies | Position | End |
|---|---|---|
| Ascletis Pharmaceuticals Co., Ltd. | Corporate Officer/Principal | 2021-11-30 |
Training of Judy Hejingdao Wu
| Zhejiang University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ASCLETIS PHARMA INC. | Health Technology |
| Private companies | 4 |
|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Ascletis BioScience Co., Ltd. | |
| Gannex LLC | |
| Ascletis Pharmaceuticals Co., Ltd. |
- Stock Market
- Insiders
- Judy Hejingdao Wu
